Introducing Sartorius’s solutions for CAR-T therapy discovery and development

Numerous challenges present themselves at the different stages of the CAR-T discovery and development process. Among these challenges are target antigen selection, on-/off-target screening, CAR delivery, appropriate tumor cell lines, animal models and their clinical relevance, tumor heterogeneity, immune escape, expansion and persistence, neurotoxicity, and cytokine release syndrome.

Sartorius supports and enables scientists like you while you strive to address these challenges. We do this by providing solutions to increase your speed and throughput, decrease your costs, and allow you to validate your results via multiparametric methods as you develop the next generation of CAR-T therapies.

> Discover Our Solutions